(Press-News.org) Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumours in particular can be difficult to treat surgically. A research team from MedUni Vienna and University Hospital Vienna has now investigated the effectiveness of a new type of therapy and achieved promising results: The active substance TVEC led to a reduction in the size of the basal cell carcinoma in all study participants, which not only improved surgical removal, but also led to a complete regression of the tumour in some of the patients. The study was published in the top journal Nature Cancer.
In the study Talimogene Laherparepvec (TVEC) was used, which has so far only been approved for the treatment of superficial melanoma metastases. TVEC is a genetically modified herpes simplex virus that specifically destroys tumour cells and simultaneously activates the immune system. The aim of the study was to reduce the size of the tumour before a planned operation so that patients would not suffer any functional or cosmetic restrictions after the procedure. The study included 18 patients who would have required a flap or skin graft due to the size and localisation of their basal cell carcinoma. They each received six intralesional injections of TVEC over a period of 13 weeks before the tumour was surgically removed.
"This enabled the tumour to be reduced in size in half of the patients to such an extent that surgery with direct wound closure was possible. In a third of the cases, the subsequent histological examination even showed no more living tumour cells. All treated tumours at least became smaller, and no tumour grew further under the therapy. The treatment was well tolerated by the patients," says the principal investigator Christoph Höller, Head of the Skin Tumour Centre at the Department of Dermatology, summarising the results. "The new treatment option for basal cell carcinoma can not only simplify surgery, but also help to avoid disfiguring operations and functional limitations," adds first author Julia Ressler, also from the Department of Dermatology. In addition to the clinical studies, the researchers from the Department of Dermatology, in cooperation with the St. Anna Children's Hospital, carried out comprehensive analyses that show that the immune defence in the tumour tissue is strengthened in the course of therapy with TVEC.
These results suggest that TVEC could be a promising option for the neoadjuvant, i.e. pre-surgical, treatment of basal cell carcinoma, particularly in patients for whom major surgery should be avoided. Further studies are to follow in order to confirm the benefits of this new option in a larger patient population.
END
Skin cancer: New treatment option successfully tested
2025-01-27
ELSE PRESS RELEASES FROM THIS DATE:
Tracking cfDNA release dynamics during colorectal cancer surgery
2025-01-27
“Taken together, our results suggest that in addition to physiological age, comorbidities and unfavorable clinical traits, intense surgical manipulation from the tumor’s extent, may result in greater tissue damage and elevated cfDNA release.”
BUFFALO, NY – January 27, 2025 – A new research paper was published in Oncotarget’s Volume 16 on January 21, 2025, titled “Assessment of cfDNA release dynamics during colorectal cancer surgery.”
Researchers from the University of Brasília investigated how cell-free DNA (cfDNA) levels in the blood change before, during, and after colorectal cancer surgery. ...
Climate study: Rise in heat deaths will substantially outweigh fewer cold deaths
2025-01-27
Climate change will likely result in a significant rise in deaths from heat across Europe, substantially surpassing any decrease in cold-related deaths. This trend persists across climate change scenarios and even under high adaptation to heat, reinforcing the need for aggressive mitigation policies.
A modelling study, led by researchers from the Environment & Health Modelling (EHM) Lab at the London School of Hygiene & Tropical Medicine (LSHTM) and published in Nature Medicine, estimates that changes to the climate could directly result in over 2.3 million additional temperature-related deaths in 854 European cities by 2099 if urgent action ...
Infant mortality rates declining, but Sudden Unexpected Infant Death is on the rise
2025-01-27
RICHMOND, Va. (Jan. 27, 2025) — Infant mortality in the United States decreased by 24.2% between 1999 and 2022. Researchers from Virginia Commonwealth University and Children’s Hospital of Richmond at VCU discovered this improvement in a study published Jan. 27 in the Journal of the American Medical Association Pediatrics. In the same study, however, they found mortality rates from Sudden Unexpected Infant Death (SUID) rose significantly – by 11.8% – from 2020 to 2022.
“Although a prior CDC study – using data until 2020 – found that Sudden Unexpected Infant Death was increasing for Black infants, ...
Severity and long-term mortality of COVID-19, influenza, and RSV
2025-01-27
About The Study: This cohort study showed that, during the 2022 to 2023 season, infection with SARS-CoV-2 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV), whereas differences were less pronounced during the 2023 to 2024 season. During both seasons, RSV remained a milder illness, whereas COVID-19 was associated with higher long-term mortality. Vaccination attenuated differences in disease severity and long-term mortality.
Corresponding Author: To contact the corresponding author, Kristina L. Bajema, MD, email kristina.bajema@va.gov.
To access the ...
Firearm-related injury hospital admissions during the COVID-19 pandemic
2025-01-27
About The Study: This cohort study evaluating hospitalizations for firearm-related injuries during the COVID-19 pandemic has 2 principal findings. From 2020 to 2021, there was a 34% increase in firearm-related hospitalizations, consistent with an additional 13,268 admissions. Second, the increase in firearm-related hospitalization disproportionately affected children, patients enrolled in Medicaid, and Black individuals. Taken together, these findings raise new concerns about the sustained increase in firearm-related injury that disproportionately ...
Sudden unexpected infant death and disparities in infant mortality in the US
2025-01-27
About The Study: This study found that infant mortality from sudden unexpected infant death (SUID) has increased significantly. Previous data through 2020 showed that SUID increased among Black infants. The current analysis, which included 2021 and 2022 data, showed a more generalized increase. Possible explanations include COVID-19 or other respiratory illnesses, maternal opioid use, and social media’s influence on infant sleeping practices.
Corresponding Author: To contact the corresponding author, Elizabeth R. Wolf, MD, ...
Predicting individual pain sensitivity using a novel cortical biomarker signature
2025-01-27
About The Study: This study provides evidence for a sensorimotor cortical biomarker signature for pain sensitivity. The combination of accuracy, reproducibility, and reliability suggests the peak alpha frequency/corticomotor excitability biomarker signature has substantial potential for clinical translation, including predicting the transition from acute to chronic pain.
Corresponding Author: To contact the corresponding author, David A. Seminowicz, PhD, email dseminow@uwo.ca.
To access the embargoed study: Visit our For The Media website at this ...
Firearm-related hospitalizations had dropped before the pandemic, then shot up, study finds
2025-01-27
Firearm injuries that sent victims to the hospital had gone down steadily over the five years before the COVID-19 pandemic began, but reversed course sharply over the next two years, a new University of Michigan study finds.
In all, 34% more people were hospitalized for a firearm-related injury in 2020 and 2021 than would have been predicted based on pre-pandemic trends.
The gap between expected and actual hospitalizations was even bigger for patients under the age of 18, those covered by Medicaid insurance for people with low incomes or disabilities, and those who are Black. The study is published in JAMA Network Open.
These ...
Novel organ recovery and logistics company celebrates 500th transplant
2025-01-27
New York, NY – January 27, 2025 – ProCure On-Demand’s 500th transplanted organ, being announced today, is emblematic of the gaps and inefficiencies in the current transplant system that the organ recovery, technology and logistics company is regularly solving.
The case involving the transplant of the 500th organ underscores ProCure's reputation for quality work, efficient logistics and swift turnaround times, which have become integral to their success. With less than five hours to recover bilateral lungs, ProCure tapped into its unique Recovery Team Network, to deploy a surgeon within seven miles ...
New research offers hope for preventing epilepsy after traumatic brain injury
2025-01-27
Monday 27 January, 2025: A new international study has unveiled critical insights in understanding post-traumatic epilepsy (PTE), a condition that can develop following traumatic brain injury. Led by researchers at FutureNeuro, the Research Ireland Centre for Translational Brain Science and RCSI University of Medicine and Health Sciences and published in Theranostics, the study highlights the important role played by a receptor in the brain called P2X7. It suggests how we could both reduce epilepsy ...